Tag: CEQ508

April 5, 2017

Marina Biotech Gives Business Update

Marina Biotech released a corporate update detailing recent changes in the company and some corporate highlights, following the filing of...
April 3, 2017

Marina Biotech Signs Deal To Make Bi-Layer Tablet

Marina Biotech signed an agreement with Windlas Healthcare Limited to manufacture IT-102 fixed-dose combination bi-layer tablets.
March 29, 2017

Marina Biotech To Show New Research At Cancer Meeting

Marina Biotech will showcase new scientific information on the use of IT-102 and IT-103 for cancer treatment during the American...
March 24, 2017

Marina Biotech Will Show New Data on Cancer Treatment

Marina Biotech (OTCQB:MRNA) will present new information on the use of antihypertensive for the treatment of cancer by targeting vascular...
March 13, 2017

Marina Biotech To Present New Findings At Annual Conference

Marina Biotech (OTCQB: MRNA) announced it will present an update at the Society of Toxicology 56th Annual Meeting in March.